Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02065284 · ClinicalTrials.gov registry record · NA

Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation in Patients With Multiple Sclerosis

A NA study of Multiple Sclerosis and Ambulation Difficulty, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT02065284 is a NA study of Multiple Sclerosis and Ambulation Difficulty that has completed, run by The Cleveland Clinic. The registered enrollment target is 32 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02065284, a NA study of Multiple Sclerosis and Ambulation Difficulty, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

Rhythmic Auditory Stimulation (RAS) is a music therapy technique that provides rhythmic auditory cues (like a beat) to help improve patients' movements, especially when walking. The purpose of this study is to compare the effect on walking performance of a home based walking program (HBWP) with Rhythmic Auditory Stimulation (RAS), to that of a HBWP without RAS, or to RAS without walking exercise. A second part of this study will assess the effects of Rhythmic Auditory Stimulation (RAS) on brain activity in patients with Multiple Sclerosis while performing mental imagery of walking.

Interventions

  • OTHER Rhythmic Auditory Stimulation (RAS)

Study Locations (1)

Ohio

  • Cleveland Clinic Neurological Institute Mellen Center - Cleveland

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2014-02
Est. Completion 2015-11
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT02065284

The ClinicalTrials.gov registry entry for NCT02065284 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (95% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Rhythmic Auditory Stimulation (RAS) is the first listed.

NCT02065284 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02065284 about?

NCT02065284 is a clinical study titled "Effects of a Home Based Walking Program Using Rhythmic Auditory Stimulation in Patients With Multiple Sclerosis". Rhythmic Auditory Stimulation (RAS) is a music therapy technique that provides rhythmic auditory cues (like a beat) to help improve patients' movements, especially when walking. The purpose of this study is to compare the effect on walking performance of a home based walking program (HBWP) with Rhy...

What is the current status of trial NCT02065284?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2014-02. Estimated completion is 2015-11.

What conditions does trial NCT02065284 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Ambulation Difficulty.

What interventions are being tested in trial NCT02065284?

The interventions under investigation include: Rhythmic Auditory Stimulation (RAS) (OTHER).

Who is sponsoring clinical trial NCT02065284?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02065284 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.